These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16905323)

  • 21. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
    Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC
    J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and dopamine transporter affinity of 2-(methoxycarbonyl)-9-methyl-3-phenyl-9-azabicyclo[3.3.1]nonane derivatives.
    Chen Z; Izenwasser S; Katz JL; Zhu N; Klein CL; Trudell ML
    J Med Chem; 1996 Nov; 39(24):4744-9. PubMed ID: 8941387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanes.
    Purushotham M; Sheri A; Pham-Huu DP; Madras BK; Janowsky A; Meltzer PC
    Bioorg Med Chem Lett; 2011 Jan; 21(1):48-51. PubMed ID: 21146984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporter.
    Lewis D; Zhang Y; Prisinzano T; Dersch CM; Rothman RB; Jacobson AE; Rice KC
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1385-9. PubMed ID: 12657288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
    Zhang S; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and nicotinic acetylcholine receptor binding affinities of 2- and 3-isoxazolyl-8-azabicyclo[3.2.1]octanes.
    Cheng J; Izenwasser S; Zhang C; Zhang S; Wade D; Trudell ML
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1775-8. PubMed ID: 15026069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.
    Meltzer PC; McPhee M; Madras BK
    Bioorg Med Chem Lett; 2003 Nov; 13(22):4133-7. PubMed ID: 14592523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters.
    Zheng G; Horton DB; Deaciuc AG; Dwoskin LP; Crooks PA
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5018-21. PubMed ID: 16905316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
    Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
    J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: new dopamine transporter inhibitors.
    Tamiz AP; Smith MP; Enyedy I; Flippen-Anderson J; Zhang M; Johnson KM; Kozikowski AP
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1681-6. PubMed ID: 10937724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of 8-thiabicyclo[3.2.1]oct-2-enes and their binding affinity for the dopamine and serotonin transporters.
    Meltzer PC; Pham-Huu DP; Madras BK
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6007-10. PubMed ID: 15546718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine.
    Greiner E; Prisinzano T; Johnson EM; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
    J Med Chem; 2003 Apr; 46(8):1465-9. PubMed ID: 12672246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.
    Choi SW; Elmaleh DR; Hanson RN; Fischman AJ
    J Med Chem; 1999 Sep; 42(18):3647-56. PubMed ID: 10479296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent and selective ligands for the dopamine transporter (DAT): structure-activity relationship studies of novel 4-[2-(diphenylmethoxy)ethyl]-1-(3-phenylpropyl)piperidine analogues.
    Dutta AK; Coffey LL; Reith ME
    J Med Chem; 1998 Feb; 41(5):699-705. PubMed ID: 9513598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationships of substituted N-benzyl piperidines in the GBR series: Synthesis of 4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(2-trifluoromethylbenzyl)piperidine, an allosteric modulator of the serotonin transporter.
    Boos TL; Greiner E; Calhoun WJ; Prisinzano TE; Nightingale B; Dersch CM; Rothman RB; Jacobson AE; Rice KC
    Bioorg Med Chem; 2006 Jun; 14(11):3967-73. PubMed ID: 16563775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and monoamine transporter binding of 2-(diarylmethoxymethyl)-3 beta-aryltropane derivatives.
    Xu L; Kulkarni SS; Izenwasser S; Katz JL; Kopajtic T; Lomenzo SA; Newman AH; Trudell ML
    J Med Chem; 2004 Mar; 47(7):1676-82. PubMed ID: 15027858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and monoamine transporter binding properties of 3beta-(3',4'-disubstituted phenyl)tropane-2beta-carboxylic acid methyl esters.
    Carroll FI; Blough BE; Nie Z; Kuhar MJ; Howell LL; Navarro HA
    J Med Chem; 2005 Apr; 48(8):2767-71. PubMed ID: 15828814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationship studies of novel 4-[2-[bis(4-fluorophenyl)methoxy]ethyl]-1-(3-phenylpropyl)piperidine analogs: synthesis and biological evaluation at the dopamine and serotonin transporter sites.
    Dutta AK; Xu C; Reith ME
    J Med Chem; 1996 Feb; 39(3):749-56. PubMed ID: 8576918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
    Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoroethoxy-1,4-diphenethylpiperidine and piperazine derivatives: Potent and selective inhibitors of [
    Hankosky ER; Joolakanti SR; Nickell JR; Janganati V; Dwoskin LP; Crooks PA
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5467-5472. PubMed ID: 29153425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.